Supernus Pharmaceuticals (S49.F) Q2 2024 Earnings

8MayConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-0.27
-0.01
0.25
0.52

Details

Expected EPS
0.24420375000000002
Actual EPS
0
Surprise EPS
-0.24
Surprise Percent
+100%

Description

Supernus Pharmaceuticals (S49.F) will report earnings of for Q2 2024 on May 08, 2024.

0 Comments

Share your thoughts